SARS-CoV-2 Spike receptor binding domain, RBD (319-335) – 0.5 mg

Overview

Explore our high-quality SARS-CoV-2 Spike Receptor Binding Domain (RBD) peptide, specifically the amino acid residues 319-335. This peptide is derived from the spike protein of SARS-CoV-2, as identified in the RefSeq database (YP_009724390.1). Designed for research and diagnostic applications, our RBD peptide is ideal for studies relating to viral binding and interaction, making it a valuable addition to your laboratory toolkit.

Key Features

• High purity and quality for reliable results
• Specifically represents the RBD of the SARS-CoV-2 spike protein
• Manufactured in compliance with strict quality standards
• Suitable for a variety of applications, including immunoassays and vaccine development
• Comes in a convenient 0.5 mg quantity

Specifications

FAQ

What is the significance of the RBD in SARS-CoV-2 research?

The receptor binding domain (RBD) is critical for the virus’s ability to attach to host cells, making it an essential target for vaccine and therapeutic development.

How can I use this peptide in my experiments?

You can utilize this peptide for various applications, including immunoassays, binding studies, and as a standard in protein quantification assays.

Is the SARS-CoV-2 RBD peptide suitable for diagnostic use?

Yes, this high-purity RBD peptide can be employed in diagnostic kits, including those designed for detecting immune responses to SARS-CoV-2.

Enhance your research capabilities with our SARS-CoV-2 Spike RBD peptide. Order now to ensure you have the materials necessary for your next breakthrough in virology!

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.